BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15609332)

  • 1. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
    Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
    van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
    Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
    Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
    Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.
    Betti M; Neri M; Ferrante D; Landi S; Biava A; Gemignani F; Bertolotti M; Mirabelli D; Padoan M; Ugolini D; Botta M; Bonassi S; Magnani C; Dianzani I
    Int J Hyg Environ Health; 2009 May; 212(3):322-9. PubMed ID: 18838334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.